SPHINGOSINE-1-PHOSPHATE RECEPTOR SUBTYPE 1: A NOVEL TARGET IN THE TREATMENT OF CHRONIC MIGRAINE

$1,663,827FY2021Defense Health AgencyDOD

University Of Maryland, Baltimore

Investigators